T he realization that mammalian cells are capable of producing hydrogen sulfide (H 2 S) has sparked interest in the biology and pharmacology of this molecule (1) (2) (3) (4) . H 2 S is now considered the third member of the gaseotransmitter family, along with nitric oxide (NO) and carbon monoxide (CO) (3) (4) (5) . H 2 S is generated from L-cysteine in reactions catalyzed by cystathionine-␤-synthase (CBS) or cystathionine-␥-lyase (CSE). CSE is primarily responsible for most of the H 2 S production in the vasculature (2, 3) , although additional pathways (e.g., 3-mercaptopyruvate sulfurtransferase) contribute also (6) . ATP-sensitive potassium channel (K ATP channel) activation contributes to H 2 S-mediated vasodilation (7) . In animal models of critical illness, H 2 S donors protect from lethal hypoxia and reperfusion injury (3, 8, 9) and exert anti-inflammatory effects (10) .
Angiogenesis is a complex biological process characterized by extracellular matrix remodeling and changes in endothelial cell (EC) behavior that lead to increased growth, migration, and assembly into capillary structures (11, 12) . Dysregulated angiogenesis contributes to tumor growth, psoriasis, arthritis, neurodegeneration, wound healing defects, and hair loss (13) . ECs are both targets and sources of H 2 S. In the vasculature, H 2 S has been mostly studied in the context of vessel tone (2, 14) . The aim of the present study was to test the role of exogenous and endogenous H 2 S in angiogenesis.
Results

H2S Promotes the Angiogenic Properties of ECs.
Exposure of human umbilical vein endothelial cells (HUVECs) to H 2 S promoted EC growth with a 2-fold increase in cell number observed at 60 M (Fig. 1A, Left) . Furthermore, H 2 S (60 ⌴) enhanced capillary-like structure formation of ECs cultured on reduced-growth factor Matrigel by 33.9 Ϯ 3.3% (n ϭ 6; P Ͻ 0.05). ECs also exhibited enhanced motility in the presence of H 2 S (Fig. 1 A, Right) . To test the ability of H 2 S to promote new blood vessel formation in vivo, we applied H 2 S in the chick chorioallantoic membrane (CAM) model. H 2 S increased the length of the vascular network in a dose-dependent manner (Fig. 1B and Fig. S1 ).
Signaling Pathways Mediating the Actions of H2S. EC exposed to H 2 S (60 ⌴) exhibited a sustained increase in ERK1/2 phosphorylation that was evident as early as 5 min (Fig. 2A) . Moreover, treatment with H 2 S led to p38 and Akt activation, but with different kinetics: phosphorylation of p38 was rapid and transient, while Akt phosphorylation showed a delayed and more sustained pattern. Inhibition of MEK by PD098059 significantly reduced H 2 S-induced EC migration, while inhibition of p38 with SB203580 completely blocked the migratory response (Fig. 2B) . Similar results were obtained using two additional inhibitors of MEK (UO126) and p38 (SB239063) (Fig. S2C) . In contrast, inhibition of the PI3/Akt pathway with LY-2924002 did not affect the migratory rate of ECs in response to H 2 S (Fig. S2 A) .
Blockade of K ATP channels in ECs by glibenclamide blocked H 2 S-induced EC migration (Fig. 2C) . Similar results were obtained with 5-hydroxydecanoate, a mitochondrial-K ATP channel selective inhibitor (5-HD; Fig. S2B ). Interestingly, incubation of ECs with the nitrate-free nicorandil analogue SG209 (a K ATP channel opener) enhanced p38 phosphorylation (Fig. S2E ) and EC motility (Fig. 2C) , suggesting that K ATP channel opening is sufficient to drive EC migration. Incubation of cells with the K ATP channel modifying agents (5-HD and SG209) did not induce apoptosis (Fig. S3 ). Hsp27 has been shown to be a downstream effector of p38 mediating its effects on cell migration (29) . Transfection of HUVECs with hsp27 siRNA resulted in reduced hsp27 protein levels; this, in turn, led to a significantly lower migratory rate of cells in response of H 2 S (Fig. 2D) . Inhibition of K ATP channels by glibenclamide blocked H 2 S-stimulated p38 and hsp27 phosphory- (Fig. S4B ). To test whether endogenously produced H 2 S contributes to the action of the prototypic angiogenic factor vascular endothelial growth factor (VEGF), cells were pretreated with PAG or BCA (Fig. 4B ), or inhibitors of K ATP channels (glibenclamide or 5-HD; Fig. S4C ), before stimulation with VEGF. All of the above agents reduced or abolished VEGF-triggered EC motility, indicating that H 2 S produced by ECs contributes to the angiogenesis-related actions of VEGF. In contrast, pretreatment of cells with glibenclamide did not affect fibroblast growth factor-induced migration (Fig. S4C) .
In line with the ability of inhibitors of H 2 S synthesis or action to reduce VEGF-stimulated migration, we observed that PAG, BCA and glibenclamide reduced ERK1/2 and/or p38 phosphorylation (Fig. 4C) . To obtain definitive confirmation of the role of endogenous H 2 S, we next used a siRNA approach to selectively reduce H 2 S production in ECs. The CSE siRNA attenuated CSE gene expression (averaged decrease of CSE protein levels was 59.8 Ϯ 6.7%), leading to attenuated activation of MAPK (ERK1/2 and p38; Fig. 4C ) and migration ( Fig. 5B ) in response to VEGF treatment.
Having proven that inhibition of CSE reduces VEGF responses, we sought to determine whether VEGF enhances H 2 S production. Indeed, exposure of HUVECs to VEGF resulted in accumulation of H 2 S in the culture medium (Fig. 5A ). The role of CSE and H 2 S production in VEGF-triggered angiogenesis was further confirmed in mice with targeted disruption of the CSE gene (CSE KO mice). Using the in vitro aortic ring angiogenesis assay, we observed a reduction in the number of microvessels formed by cultured aortic rings from CSE knockouts, both basally and following VEGF stimulation, compared to littermate controls ( Fig. 5C and Fig. S1B ). The lack of an additive effect of maximal doses of VEGF and exogenously administered H 2 S with regards to cell motility (Fig.  S4D) suggests that optimal amounts of this gaseous mediator are already produced following VEGF exposure.
H2S Promotes Wound Healing. To study whether H 2 S administration exerts therapeutic benefits related to angiogenesis in vivo, we used a burn wound assay (30% of the total body surface area). Wound closure after 1 month was markedly improved in animals receiving daily topical administrations of H 2 S. Re-epithelialization, as a percent of original wound size, significantly increased from 16 Ϯ 3% to 24 Ϯ 1% (n ϭ 6, P Ͻ 0.05). To determine the role of endogenously produced H 2 S we compared wound healing in the CSE Ϫ/Ϫ and CSE ϩ/ϩ mice ( Fig. 5D and Fig. S1C ). Throughout the observation period, wound areas in CSE ϩ/ϩ mice were consistently smaller than in CSE Ϫ/Ϫ mice, suggesting that healing is delayed when endogenous H 2 S production is suppressed.
Discussion
EC proliferation, migration, and differentiation are key properties associated with blood vessel formation (11). Previous reports have shown that H 2 S can affect the proliferation and survival of mammalian cells with experiments in vascular cells yielding opposing effects. H 2 S promotes apoptosis in smooth muscle cells (15) , while it exerts a mitogenic effect in rat retinal ECs (16) . Our results demonstrate that incubation of human ECs with H 2 S results in a concentration-dependent increase in cell number. Thus, similar to nitric oxide, H 2 S promotes the growth of EC, while inhibiting that of smooth muscle (17, 18) . H 2 S also stimulates capillary morphogenesis to drive network-like formation of ECs in vitro. Moreover, H 2 S exerted a positive effect on endothelial migration, suggesting that H 2 S promotes the appearance of an angiogenic phenotype by the endothelium. Results from the CAM experiments further proved that exogenous H 2 S increases neovascularization. This is consistent with a report from Moore and colleagues, where H 2 S was shown to induce a dose-dependent effect on angiogenesis using the Matrigel model (16) . The finding that H 2 S promotes angiogenesis is also in agreement with the ability of H 2 S to promote the healing of gastric ulcers and of colitic intestinal ulcerations (19, 20) . Along these lines, in the present study, we observed that H 2 S promoted the healing of burn wounds, where angiogenesis occurs mainly during the proliferative phase of wound healing and is crucial in promoting re-epithelialization and closure. Thus, H 2 S donor compounds may exhibit therapeutic potential as stimulators of therapeutic angiogenesis and wound healing.
We have identified several downstream effectors of H 2 S in ECs. H 2 S has been reported to alter the activation status of ERK1/2 and p38 in a cell-type and stimulus-dependent manner. For example, H 2 S activates ERK1/2 in gastric epithelial cells (21) , monocytes (22) , and smooth muscle cells (15) , while inhibits ERK1/2 phosphorylation in beta cells (23) . In addition, H 2 S activates p38 in beta cells and smooth muscle (15) , while it inhibits p38 phosphorylation in neutrophils (24) and microglia (25) . In contrast to what was reported in transformed ECs (16) where exposure to H 2 S did not affect ERK1/2 phosphorylation, we found that incubation of HUVECs with H 2 S activates ERK1/2 as well as p38. Pharmacological inhibitors of MEK and p38 attenuated H 2 S-stimulated responses. Thus, in the conditions used in the current study, MAPK, but not PI-3K, pathways are involved in the H 2 S-stimulated migration in human ECs. Some of the actions of H 2 S have been attributed to K ATP channel opening (7, 10) . EC express K ATP channels both in the plasma membrane and in intracellular organelles (26, 27) . The K ATP channel inhibitors glibenclamide or 5-HD blocked the migratory response to H 2 S. Furthermore, incubation of cells with the K ATP channel opener SG209 (28), induced a concentration-dependent migratory response, indicating that K ϩ efflux per se can drive EC motility. Another group has reported that blockade of Ca 2ϩ -activated K ϩ channels also attenuates EC growth and angiogenesis (29) .
Hsp27 is a modifier of actin cytoskeleton which regulates cell migration (30) (31) (32) . Phosphorylation of actin-bound hsp27 allows actin polymerization to proceed (33) . Hsp27 is directly phosphorylated by MAPKAP (a p38 substrate) (34, 35) . We report here that hsp27 is phosphorylated after exposure to H 2 S and this was blocked by p38 inhibition. Glibenclamide reduced p38 and hsp27 phosphorylation, suggesting the existence of a K ATP channel/p38/hsp27 pathway that leads to migration. A role for K ATP channels in regulating MAPK pathways has also been demonstrated in other experimental models previously (36) . The finding that knockdown of hsp27 using siRNA inhibited the effects of H 2 S proves the existence of a K ATP /p38/hsp27 axis regulating H 2 S migration.
To determine the contribution of endogenous H 2 S to angiogenesis, we used two different pharmacological inhibitors of H 2 S production, which both decreased the length of vascular networks, as well as their branching, suggesting that endogenously produced H 2 S plays a tonic stimulatory role in the angiogenetic process: it is conceivable, therefore, that H 2 S produced in the eggs may serve as a physiological hormone for the developing chicken embryo vasculature.
Since endothelial CSE activity is known to be stimulated by calcium/calmodulin (14), we hypothesized that exposure of ECs to the potent endogenous angiogenic agent VEGF, which promotes elevations in intracellular calcium levels (37), may lead to H 2 S release that in turn contributes to VEGF-stimulated angiogenesis-related properties of ECs. Indeed, we have shown here that exposure of HUVECs to VEGF stimulates the cellular release of H 2 S. Moreover, pretreatment of cells with PAG, glibenclamide, or CSE gene knockdown, attenuated VEGF signaling, as indicated by the reduction in ERK1/2 and p38 phosphorylation. In line with the ability to reduce VEGF signaling, inhibition of H 2 S production (PAG, BCA, or CSE siRNA) or action (glibenclamide) attenuated VEGF-induced migration. To determine whether endogenously produced H 2 S contributes to other angiogenesis-related actions of VEGF, we studied the ability of this growth factor to trigger an angiogenetic response in vascular tissues from CSE Ϫ/Ϫ mice. Exposure of aortic rings from wild-type animals to VEGF stimulated the growth of microvessels; this was not observed in vessels from CSE Ϫ/Ϫ mice, further confirming the role of endogenous H 2 S in neovascularization and in wound healing.
In summary, we have shown that H 2 S stimulates angiogenesisrelated properties of ECs and blood vessel formation in vivo. H 2 S exerts its effects on ECs through K ATP channels that in turn facilitate activation of MAPK pathways, leading to new blood vessel formation. Thus, we hypothesize that (a) H 2 S and other K ATP channel activators may be useful in disease states associated with poor neovascularization and (b) that inhibition of endogenous H 2 S production may be useful in conditions of pathological/excessive angiogenesis.
Materials and Methods
EC Proliferation and Migration. HUVECs were isolated from 3-5 umbilical cords and grown in M199 supplemented with 15% FBS, antibiotics, 5 U/mL heparin, and 150 -200 g/mL EC growth supplement (ECGS). Cells were treated with H2S (6 -600 M) and allowed to proliferate for 48 h. Cells were then trypsinized and counted. To measure cell migration, cells were serum-starved overnight, trypsinized, and added to Transwell inserts. After the treatment with various pharmacological agents, cells were allowed to migrate for 4 h at 37°C. After fixation and staining, migrated cells were scored in eight random fields.
Matrigel Tube-Like Structure Formation Assay and In Vitro Angiogenesis Assay. HUVECs (15,000 cells/well) were plated in 96-well plates precoated with 50 L growth factor-reduced Matrigel. Following a 24 h-incubation, tube formation was quantified by image analysis software (Scion Image). Microvessel formation was also evaluated using the in vitro aortic ring angiogenesis assay. Each 3-mm aortic ring was housed in a 48-plate fibrin gel containing complete medium overnight. Medium was then removed and VEGF (20 ng/mL) or vehicle added for 72 h. Quantitative evaluation of newly formed structures was carried out via an inverted microscope.
Western Blots. Cells were starved for 5 h and then treated with H 2S or vehicle. Cell lysates were collected every 5 min for a duration time of 20 min. After SDS/PAGE, and transfer, membranes were immunoblotted with antibodies specific for the phosphorylated or total form of p38, ERK1/2 or hps27 or Akt. After incubation with secondary antibodies, band location was revealed with the use of a chemiluminescent substrate.
In Vivo CAM Angiogenesis Assay. Fertilized White Leghorn chicken eggs were placed in an incubator as soon as embryogenesis started and kept under constant humidity at 37°C. On day 4, a square window was opened in the shell and then sealed with adhesive tape. On day 9, an O-ring (1 cm 2 ) was placed on the surface of the CAM and the substance tested was added inside this restricted area. After 48 h, CAM tissues were fixed in Carson's solution (saline-buffered formalin) and angiogenesis was evaluated using the NIH image analysis software.
Measurement of H 2S Production. H2S production rate was measured via the methylene blue assay (15) .
Wound Healing Models. Male Sprague-Dawley rats were anesthetized with ketamine (60 mg/kg) and xylazine (10 mg/kg) i.p. Rats were shaved, placed in a mold, and burned by submerging the back of the animal in scalding (95-99°C) water for 10 s. Animals were treated with vehicle (n ϭ 6), or daily s.c. injections of 300 g/kg H2S in the volume of 50 L per injection, at four equally spaced sites in the transition zone between burn site and healthy tissue. Re-epithelization was determined on day 31 by planimetry. For the murine studies, second generation of 16-week-old male CSE Ϫ/Ϫ and wild-type littermate mice were used. An approximate 100-mm 2 scald wound (5% total body-surface area) was created on the dorsal surface of the animals using a heated metal stick. Wound size was determined every third day and quantified using AlphaEase FC (v5.0.1) Data Analysis. Data are expressed as means Ϯ SEM. Statistical comparisons between groups were performed using ANOVA followed by a post-hoc or Student's t test.
